Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology

...n immunoglobulin genes. "Creating a knockout rat was the biggest challenge omt faced," said Dr. Roland Buelow, CEO of omt and a senior author of the paper. "Inactivation of endogenous rat antibody...

SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine

...s for inclusion in the two trial arms of BARI-2D - omt alone or omt plus revascularization - all patients received an ...n. The BARI-2D trial set out to evaluate whether omt alone or...

OMT in Medical Products

Calypte Aware HIV-1/2 OMT Rapid Test

Description: The Calypte AwareTM HIV-1/2 OMT test is a single use, qualitative, visually read, in vitro immunoassay for the detection of antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) in human oral mucosal transudate specimens. It is intended for use as a point-of-care aid in t...
Company:Calypte Biomedical Corp

OMT in Biological Technology

OMT announces a breakthrough in the development of a novel human antibody platform

..."Creating a knockout rat was the biggest challenge omt faced", said Dr. Roland Buelow, CEO of omt and senior author of the paper. "Inactivation of ... genetic engineering of animals." In the study, omt scientists and its collaborators used ZFNs develop...

Sangamo BioSciences Announces License Agreement For the Use of ZFP Technology For Generation of Transgenic Animals

...will provide a non-exclusive, worldwide license to omt for the commercial use of transgenic animals gener... zinc finger DNA-binding protein (ZFP) technology. omt will pay Sangamo an upfront license fee, payments ...opment milestones, a share of payments received by omt from sublicensees, and royalties on sales of any p...